We provide medical care services to many patients with degenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), spinocerebellar degeneration, and dementia; autoimmune nervous diseases such as multiple sclerosis (MS) and myasthenia gravis; metabolic muscle diseases such as mitochondrial encephalomyopathy; peripheral neuropathy such as Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and Charcot-Marie-Tooth disease; epilepsy, migraine and involuntary movement.
To treat cerebrovascular disorder (stroke), non-invasive test methods including imaging procedure and ultrasonography are applied to patients who are at the chronic stage or at risk of showing no symptoms, in order to provide the most suitable primary/recurrent stroke prevention. At the acute stage, we strive to proactively apply thrombolytic therapy with tPA intravenous injection, rapid diagnosis of disease type, and acute-stage rehabilitation to stroke patients. The number of beds was increased to three in the SCU in 2010 to provide stroke patients at the acute stage with further improved medical services, including treatment, nursing care, and rehabilitation services.
As described above, we treat patients with all neurological diseases excluding psychiatric disorders.